Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship of dementia screening tests with biomarkers of Alzheimer's disease.

Brain : a journal of neurology - 1 Nov 2010

Galvin James E, Fagan Anne M, Holtzman David M, Mintun Mark A, Morris John C

Abstract excerpt

Screening tests for Alzheimer's disease lack sensitivity and specificity. We developed the AD8, a brief dementia screening interview validated against clinical and cognitive evaluations, as an improvement over current screening methods. Because insufficient follow-up has occurred to validate the AD8 against the neuropathologic findings of Alzheimer's disease, we investigated whether AD8 scores correspond to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dementia

Share to Genetic Testing

Share to Longitudinal Studies

Share to Mass Screening

Share to Peptide Fragments

Source

Open in PubMed Open full text

Identifiers

PMID: 20823087
DOI: 10.1093/brain/awq204
PMCID: PMC2965421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship of dementia screening tests with biomarkers of Alzheimer's disease.PMID 20823087Read ↗

New horizons in the diagnosis and management of Alzheimer's Disease in older adults.Semantic proximity Read ↗

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersSemantic proximity Read ↗

The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer’s DiseaseSemantic proximity Read ↗

Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.Semantic proximity Read ↗

Scalable Markers for Early Cognitive Decline: Plasma p-tau217, Subjective Cognitive Concerns, and Digital Testing: Results from the A4/LEARN studiesSemantic proximity Read ↗

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.Semantic proximity Read ↗

Evaluation and use of diagnostic tests in Alzheimer's disease.Semantic proximity Read ↗

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersSemantic proximity Read ↗

The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease.Semantic proximity Read ↗

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.Semantic proximity Read ↗

Use of Biomarkers in Clinical Trials of Alzheimer DiseaseSemantic proximity Read ↗

Challenges associated with biomarker‐based classification systems for Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.